Literature DB >> 24677525

Structural speculation and identification of alkaloids in Macleaya cordata fruits by high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry combined with a screening procedure.

Zhi-Xing Qing1, Pi Cheng, Xiu-Bin Liu, Yi-Song Liu, Jian-Guo Zeng, Wei Wang.   

Abstract

RATIONALE: Alkaloids with significant therapeutic effects are the main active constituents of Macleaya cordata, which is a perennial herb plant in the Papaveraceae family. A systematic and novel method for speculating and identifying the structures of alkaloids in M. cordata fruits by high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry (HPLC/Q-TOF-MS) with a screening procedure was reported.
METHODS: Investigation of mass spectral fragmentation of alkaloids was carried out based on the tandem mass spectrometry (MS/MS) data analyses of eight reference substances. The skeletons of alkaloids were determined by their ultraviolet spectra (UV) and MS/MS data. The substituent groups of the alkaloids were acquired through a screening procedure developed in our laboratory and MS/MS data. The substituent linkage sites were deduced by MS/MS fragmentation behavior, as well as biosynthetic pathways of related alkaloids.
RESULTS: The structures of 21 alkaloids were speculated in this study, 10 of which were reported for the first time in M. cordata. Furthermore, benzyltetrahydroisoquinoline and N-methyltetrahydroprotoberberine-type alkaloids were discovered, which indirectly proved that the biosynthetic pathways of benzophenanthridine alkaloids reported in Eschscholtzia california existed in M. cordata as well.
CONCLUSIONS: HPLC/Q-TOF-MS combined with a screening procedure was a systematic and reliable method for speculating and elucidating the structures of alkaloids. This study might be useful for the identification of other compounds in herbal medicines.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24677525     DOI: 10.1002/rcm.6874

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Inhibitors Targeting Multiple Janus Kinases From Zanthoxylum simulans Mediate Inhibition and Apoptosis Against Gastric Cancer Cells via the Estrogen Pathway.

Authors:  Yong-Qiang Tian; Dai Hu; Yong-Li Zhang; Jian Zou; Gui-Lin Chen; Ming-Quan Guo
Journal:  Front Chem       Date:  2022-06-06       Impact factor: 5.545

2.  LC-MS guided isolation of three pairs of enantiomeric alkaloids from Macleaya cordata and their enantioseparations, antiproliferative activity, apoptosis-inducing property.

Authors:  Chunmei Sai; Dahong Li; Shengge Li; Tong Han; Yongzhi Guo; Zhanlin Li; Huiming Hua
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

3.  Profiling and Pharmacokinetic Studies of Alkaloids in Rats After Oral Administration of Zanthoxylum nitidum Decoction by UPLC-Q-TOF-MS/MS and HPLC-MS/MS.

Authors:  Aihua Huang; Yuguang Chi; Jiawei Liu; Mincun Wang; Jialiang Qin; Lijuan Ou; Weiwen Chen; Zhongxiang Zhao; Ruoting Zhan; Hui Xu
Journal:  Molecules       Date:  2019-02-07       Impact factor: 4.411

4.  Preclinical safety evaluation of Macleaya Cordata extract: A re-assessment of general toxicity and genotoxicity properties in rodents.

Authors:  Zhen Dong; Shu-Sheng Tang; Xiao-Lan Ma; Chang-Hong Li; Zhao-Shan Tang; Zi-Hui Yang; Jian-Guo Zeng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

5.  Identification of the Impurities in Bopu Powder® and Sangrovit® by LC-MS Combined with a Screening Method.

Authors:  Zhuang Dong; Mengting Liu; Xiaohong Zhong; Xiaoyong Ou; Xuan Yun; Mingcan Wang; Shurui Ren; Zhixing Qing; Jianguo Zeng
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

6.  Comparative study on alkaloids and their anti-proliferative activities from three Zanthoxylum species.

Authors:  Yongqiang Tian; Chunyun Zhang; Mingquan Guo
Journal:  BMC Complement Altern Med       Date:  2017-09-12       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.